Skip to main content
MLTX logo
MLTX
(NASDAQ)
MoonLake Immunotherapeutics
$17.36-- (--)
Loading... - Market loading

MoonLake Immunotherapeutics (MLTX) Balance Sheet

Assets, liabilities, and shareholders' equity with annual and quarterly data.

MoonLake Immunotherapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for MoonLake Immunotherapeutics (MLTX) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Current Assets
Cash and Cash Equivalents334.52180.43451.1739.518.041.34
Short-Term Investments59.45267.6059.8432.610.000.00
Cash & Short-Term Investments393.97448.03511.0172.118.041.34
Accounts Receivable4.872.841.060.220.150.00
Inventory0.000.000.000.000.000.00
Other Current Assets22.8623.422.104.181.450.28
Total Current Assets421.69474.29514.1776.519.641.62
Non-Current Assets
Property, Plant & Equipment (Net)2.143.643.950.330.050.00
Long-Term Investments0.000.000.000.00115.04115.01
Other Non-Current Assets0.600.008.420.00-115.040.00
Total Non-Current Assets2.743.6412.370.330.05115.01
Total Assets424.43477.93526.5476.849.68116.63
Current Liabilities
Accounts Payable0.000.221.460.050.030.00
Short-Term Debt1.231.371.200.1515.000.06
Accrued Liabilities11.2720.238.076.044.760.00
Other Current Liabilities44.2411.776.937.351.230.07
Total Current Liabilities45.4822.469.977.6721.090.13
Non-Current Liabilities
Long-Term Debt74.851.462.500.130.000.00
Other Non-Current Liabilities-0.370.620.580.280.244.03
Total Non-Current Liabilities74.472.083.080.410.244.03
Total Liabilities119.9524.5413.058.0821.334.15
Stockholders' Equity
Common Stock0.010.010.010.010.04115.00
Retained Earnings-462.91-235.59-116.66-80.65-53.64-2.52
Accumulated Other Comprehensive Income0.605.002.360.35-0.170.00
Treasury Stock0.000.000.000.000.010.00
Additional Paid-in Capital766.78677.41609.97129.1942.060.00
Minority Interest0.006.5717.8219.870.000.00
Shares Outstanding71.3763.0860.4738.9836.930.00
Total Stockholders' Equity304.48453.39495.6848.9042.00112.48
Total Liabilities & Equity424.43477.93526.5476.849.68116.63

Frequently Asked Questions About MoonLake Immunotherapeutics Balance Sheet

What is a balance sheet?

A balance sheet shows a company's financial position at a specific point in time. It lists total assets (what the company owns), total liabilities (what it owes), and stockholders' equity (the difference). The fundamental equation: Assets = Liabilities + Equity.

What is stockholders' equity?

Stockholders' equity represents the net value belonging to shareholders — total assets minus total liabilities. It includes retained earnings, common stock, and additional paid-in capital. Growing equity over time typically indicates a healthy, profitable business.

What is working capital?

Working capital is current assets minus current liabilities. It measures a company's ability to pay short-term obligations with short-term assets. Positive working capital indicates the company can cover its near-term debts; negative may signal liquidity risk.

What is MLTX's debt level?

Review MoonLake Immunotherapeutics's total long-term debt and short-term borrowings in the balance sheet table above. Compare debt to equity and total assets to assess leverage and financial risk.

What is book value per share?

Book value per share is total stockholders' equity divided by shares outstanding. It represents the accounting value per share if the company were liquidated. Comparing market price to book value gives the price-to-book (P/B) ratio — a key valuation metric.

These financial metrics are calculated using balance sheet data. Learn how each metric works and screen stocks by them.